leadership
confidence high
sentiment neutral
materiality 0.55
Bellerophon CEO Peter Fernandes and VP Parag Shah to depart under separation agreements
Bellerophon Therapeutics, Inc.
- CEO Peter Fernandes' separation effective Nov 15, 2023; receives lump sums of $205,950 plus two $102,975 payments.
- VP Parag Shah's separation effective Aug 31, 2023; receives $140,600 upfront and $140,600 later.
- Both will perform transition duties until separation dates and have signed release of claims and non-solicit covenants.
- No successor or interim appointments announced for either departing executive.